Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Change in Account Payables (2016 - 2026)

Niagen Bioscience has reported Change in Account Payables over the past 13 years, most recently at -$1.9 million for Q4 2025.

  • Quarterly Change in Account Payables fell 186.03% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 312.75% year-over-year, with the annual reading at $2.3 million for FY2025, 312.75% up from the prior year.
  • Change in Account Payables was -$1.9 million for Q4 2025 at Niagen Bioscience, down from -$938000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $3.0 million in Q2 2025 and troughed at -$2.3 million in Q1 2024.
  • The 5-year median for Change in Account Payables is -$87500.0 (2021), against an average of $99500.0.
  • Year-over-year, Change in Account Payables plummeted 229.26% in 2022 and then soared 1379.61% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at -$381000.0 in 2021, then surged by 246.98% to $560000.0 in 2022, then skyrocketed by 84.64% to $1.0 million in 2023, then surged by 118.76% to $2.3 million in 2024, then crashed by 186.03% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Change in Account Payables are -$1.9 million (Q4 2025), -$938000.0 (Q3 2025), and $3.0 million (Q2 2025).